Recombinant Human BMP-4

Cat No. Size Price Add Cart
HST-B4-0010 10ug $ 208.00 Add Cart
HST-B4-0100 100ug $ 1491.00 Add Cart
HST-B4-1000 1000ug $ 6390.00 Add Cart

Product Specifications

•      Expression of Human Proteins in Human Cells

•      Extreme low Endotoxin

•      High Purity

•      Animal Free and Xeno Free

•      Tag Free


Source: Human cells derived

Structure: Glycosylated homodimer

Purity: >95% by SDS-PAGE

Endotoxin Level: <0.5EU/ug

Molecular Weight: 34-40kDa

Formulation: Lyophilized from a 0.2μm filtered solution in PBS without carrier protein


Activity Assay

The activity was measured by its ability to induce alkaline phosphatase production in the ATDC-5 cell line (Mouse chondrogenic cell line).



Briefly  centrifuge  the  vial  before  opening.  It  is recommended to reconstitute the protein in sterile

4 mM  HCl  containing  at  least  0.1%  human  or bovine serum albumin.


Stability & Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. In general: 12 months from date of receipt, -20 to -80°C as supplied. 1 month, 2to 8°C under sterile conditions after reconstitution. 3 months, -20 to -80°C under sterile conditions after reconstitution.


Protein Description

Bone morphogenetic protein 4 (BMP-4) is a member of transforming growth factor β family that includes more than 20 structurally related bone growth factors. BMP-4 is widely expressed from early embryogenesis through dulthood. It plays an important role in cartilage and bone formation, mesoderm induction, tooth development, limb formation and fracture repair. Mature human BMP-4 is a 116 amino acids glycoprotein and normally found as a homodimer. Dimerization is facilitated by a disulfide bridge formed between the monomer, which contains three intrachain disulfide bridges arranged in a cystine knot motif. BMP-4 signals through tetrameric complexes composed of type I (primarily Activin RIA or BMPRIA) and type II (primarily Activin RIIA or BMPRII) receptors. The bioavailability of BMP-4 is regulated by its interaction with multiple proteins and glycosaminoglycans.



Zhang Y, et al. (2008)Blood 111,1933.

Shore EM, et al. (1998)Calcif. Tissue Int. 63,221-229.

Nakamura K, et al. (1999)Exp. Cell Research 250,351-363.